Importance of asymmetrical dimethylarginine in cardiovascular risk

Lancet. 2001 Dec;358(9299):2096-7. doi: 10.1016/S0140-6736(01)07229-4.
No abstract available

Publication types

  • Comment

MeSH terms

  • Arginine / blood*
  • Arginine / urine
  • Biomarkers
  • Cardiovascular Diseases / blood*
  • Cardiovascular Diseases / epidemiology
  • Comorbidity
  • Humans
  • Kidney Failure, Chronic / blood*
  • Kidney Failure, Chronic / epidemiology
  • Risk Assessment

Substances

  • Biomarkers
  • Arginine